HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (10) Citing Articles via Google Scholar Google Scholar Articles by Ellmers, L. J Articles by Cameron, V. A Search for Related Content PubMed PubMed Citation Articles by Ellmers, L. J Articles by Cameron, V. A

¹ Christchurch Cardioendocrine Research Group, Department of Medicine, Christchurch School of Medicine and Health Sciences, PO Box 4345, Christchurch, New Zealand
² Department of Pharmacology and Toxicology, Biocenter Oulu, University of Oulu, 90014 Oulu, Finland
³ Department of Pathology and Laboratory Medicine, University of North Carolina, Chapel Hill, North Carolina 27599-7525, USA

(Requests for offprints should be addressed to L J Ellmers; Email: leigh.ellmers{at}chmeds.ac.nz)

The natriuretic peptides, atrial (ANP) and brain natriuretic peptide (BNP) are known to suppress cardiac hypertrophy and fibrosis. Both ANP and BNP exert their bioactivities through the Npr1 receptor, and Npr1 knockout mice (Npr1–/–) exhibit marked cardiac hypertrophy and fibrosis. In this study, we investigated which genes within the hypertrophic and fibrotic pathways are influenced by the lack of Npr1 signalling. cDNA microarray and quantitative real-time PCR (RT-PCR) analyses were performed on cardiac ventricles from Npr1–/–mice. Gene expression at early and late stages during development of hypertrophy wasinvestigated in male and female Npr1–/–mice at8 weeks and 6 months of age. Heart weight to body weight ratios (HW:BW) were maximally increased in 8-week males (P < 0.01), whilst HW:BW in females continued to increase progressively up to 6 months (P < 0.01). This was despite blood pressure being similarly elevated at both the ages in male and female knockout when compared with wild-type (WT) mice (P < 0.001). Microarray analysis identified altered gene expression at the earliest steps in the hypertrophy-signalling cascade in Npr1–/– mice, particularly calcium–calmodulin signalling and ion channels, with subsequent changes in the expression of intracellular messengers including protein kinases and transcription factors. Real-time PCR analysis confirmed significant differences in gene expression of ANP, BNP, calmodulin 1, histone deacetylase 7a (HDAC7a), protein kinase C (PKC), (GATA) 4, collagen 1, phospholamban and transforming growth factor-ß1 in Npr1–/– mice when compared with WT (P < 0.05). The present study implicates the calmodulin–CaMK–Hdac–Mef2 and PKC–MAPK–GATA4 pathways in Npr1 mediation of cardiac hypertrophy.

This article has been cited by other articles:

				P. Kumar and K. N. Pandey Cooperative Activation of Npr1 Gene Transcription and Expression by Interaction of Ets-1 and p300 Hypertension, July 1, 2009; 54(1): 172 - 178. [Abstract] [Full Text] [PDF]

				L. J. Ellmers, N. J. A. Scott, S. Medicherla, A. P. Pilbrow, P. G. Bridgman, T. G. Yandle, A. M. Richards, A. A. Protter, and V. A. Cameron Transforming Growth Factor-{beta} Blockade Down-Regulates the Renin-Angiotensin System and Modifies Cardiac Remodeling after Myocardial Infarction Endocrinology, November 1, 2008; 149(11): 5828 - 5834. [Abstract] [Full Text] [PDF]